https://greenpublishers.org/jms/index.php/gjiad/issue/feed 2021-11-03T03:54:01+00:00 Open Journal Systems <p><strong>Global journal of Immunology and Allergic Diseases</strong> is a peer reviewed scientific journal providing an authoritative setting for the publication of high quality internationally-relevant research that is essential to the future of immunology and allergic diseases. The goal of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of immunology and allergic diseases.</p> https://greenpublishers.org/jms/index.php/gjiad/article/view/44 2021-11-03T03:46:23+00:00 Michael Mncedisi Willie m.willie@medicalschemes.com Phakamile Nkomo info@greenpublishers.org

<p>Digital transformation is growing at a slow rate in medical schemes or healthcare compared to other industries such as banking and insurance. The healthcare sector needs to embrace the digital transformation and adopt and optimize on use of technology, otherwise, the sector will be left behind. Other sectors have taken advantage of technology, for example in the retail sector, nowadays people shop online, bank, and do travel bookings online. The logistic business has also embraced digital transformation in that most activities are now done through devices at the convenience of one's office or home. The recent HPCSA¹ conference included topics such as Telemedicine's where several digital transformation and innovations in the health sector were also presented. What was evident in the discussions was that progress in accelerating digital transformation is pounded by a slow pace of regulation and other relevant guidelines. The topics discussed clearly revealed that the health sector is still far behind compared to other countries. For example, there is a gap in the adoption of digitally enabled tools for diagnosing, providing treatment, and better management of chronic conditions and other conditions. Electronic medical records are still not a part of routine care both from the supply and the funders side except a handful of players.</p>

2019-10-10T00:00:00+00:00 Copyright (c) 2021 https://greenpublishers.org/jms/index.php/gjiad/article/view/45 2021-11-03T03:54:01+00:00 Sten Dreborg sten.dreborg@kbh.uu.se Gina Tsai info@greenpublishers.org Harold Kim info@greenpublishers.org

<p>Background: Some overweight and obese adults have an increased risk of subcutaneous injection using epinephrine autoinjectors (EAIs). Needle lengths of EAIs vary between brands and lots. Objective: To study if BMI or height adds information to define adults at risk of having intraosseous or subcutaneous injection. Methods: Ninety-nine (99) food allergic adult patients, 32 men and 67 women, 18 - 72 years of age, prescribed EAIs were included. The skin to muscle and skin to bone distances were measured by ultrasonography. The effect of injection on naked skin or through thick clothing was analyzed. High and minimal pressure was applied to the ultrasound probe. Results: Two of three men and 1/5 women with BMI &lt;20 had a risk of intraosseous/periosteal injection using the high pressure autoinjector Epipen^®, thick clothing, 5/8. Injecting through naked skin using the shortest needle, 14/17 obese women had a high risk of subcutaneous injection (overweight 14/23), through thick clothing all 17 obese women would have a risk of subcutaneous injection (overweight 20/23). Injecting with LPEAIs through naked skin, using the shortest needle 8/17 obese and 4/23 overweight women would have a risk of subcutaneous injection, wearing thick clothing, 10/17 obese and 7/23 overweight women. Height had no predictive value. Conclusion: Using high pressure EAIs, high BMI predicted a very high risk for subcutaneous injection in women and in some men. Even injection with low pressure EAIs had some risk of subcutaneous injection, especially when injected through thick clothing. Height had no predictive value.</p>

2019-12-30T00:00:00+00:00 Copyright (c) 2021